Company Data
CNS Pharmaceuticals Inc.
Ticker
CNSP
Current Price
$1.05 -1.87%
Market Cap
$5.7M
Price Target
Refer to Report
Volume
88.7K
52wk Range
$0.771525 - $31862.5
Overview
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.